Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

CBPO
China Biologic Products Holdings, Inc.
stock NASDAQ

Inactive
Apr 20, 2021
119.99USD+1.678%(+1.98)390,921
Pre-market
0.00USD-100.000%(-118.01)0
After-hours
0.00USD0.000%(0.00)0
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Apr 21, 2021
07:31AM EDT  The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue   Benzinga
Apr 20, 2021
04:33PM EDT  China Biologic Products Announces Completion Of Its Merger With CBPO Group   RTTNews
04:30PM EDT  China Biologic Announces Completion of Going Private Transaction   PR Newswire
Mar 29, 2021
04:39PM EDT  China Biologic Products Inc. (CBPO) revealed earnings for its fourth quarter that rose from last year.   RTTNews
04:31PM EDT  China Biologic Products Q4 Adj. EPS $0.91 Up From $0.53 YoY, Sales $112.10M Up From $102.20M YoY   Benzinga
04:30PM EDT  China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year   PR Newswire
Mar 1, 2021
08:14AM EST  China Biologic Announces Shareholders' Approval Of Merger Agreement   Benzinga
Feb 18, 2021
08:14AM EST  The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout   Benzinga
Feb 17, 2021
07:27AM EST  The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal   Benzinga
Jan 25, 2021
08:56AM EST  China Biologic Reports Extraordinary General Meeting Of Shareholders   RTTNews
08:51AM EST  China Biologic Announces Extraordinary General Meeting Of Shareholders   Benzinga
Dec 31, 2020
06:17AM EST  China Biologic Products Amended 13D Filings From CITIC Capital, PW Medtech Show 12,8%, 9.7% Stakes, Respectively   Benzinga
Dec 1, 2020
08:08AM EST  The Daily Biotech Pulse: Pfizer, BioNTech File Marketing Application In Europe, NuCana Jumps On Data, Amarin Takes On Hikma In Patent Lawsuit   Benzinga
Nov 24, 2020
04:45PM EST  China Biologic Q3 EPS $0.99 Vs. $1.21 Year Ago   RTTNews
04:39PM EST  China Biologic Products Inc. (CBPO) revealed a profit for third quarter that fell from the same period last year.   RTTNews
04:32PM EST  China Biologic Products Q3 EPS $1.39 Beats $1.28 Estimate, Sales $138.50M Up From $136.11M YoY   Benzinga
04:30PM EST  China Biologic Reports Financial Results for the Third Quarter of 2020   PR Newswire
08:13AM EST  The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia   Benzinga
04:03AM EST  Earnings Scheduled For November 24, 2020   Benzinga
Nov 20, 2020
08:06AM EST  The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger   Benzinga
Nov 19, 2020
10:12AM EST  Shares of China Biologic Products Holdings Inc. (CBPO) reached a 52-week high of $118.90 Thursday morning, and are currently trading at $118.30, up $3.34 or 2.91%, with trading volume surging over 260K versus an average volume of 85K shares.   RTTNews
08:44AM EST  China Biologic Products Holdings Inc. (CBPO) agreed to be taken private by CBPO Holdings Limited in a deal implying an equity value of the company of about US$4.76 billion.   RTTNews
08:27AM EST  China Biologic Enters Into Definitive Merger Agreement For Going Private Transaction; Each Ordinary Share Will Be Cancelled For Right To Receive $120 In Cash   Benzinga
08:13AM EST  China Biologic Reaches Merger Deal For Going Private Transaction; Deal Implying Equity Value Of Company Of US$4.76 Bln   RTTNews
08:10AM EST  China Biologic Enters into Definitive Merger Agreement for Going Private   PR Newswire
Nov 13, 2020
08:00AM EST  China Biologic Products to Report Third Quarter 2020 Financial Results   PR Newswire
Aug 17, 2020
04:43PM EDT  China Biologic Products Inc. (CBPO) announced a profit for second quarter that declined from last year.   RTTNews
04:36PM EDT  China Biologic Q2 EPS $0.91 Vs. $1.06 Year Ago   RTTNews
04:31PM EDT  China Biologic Products Q2 EPS $1.11 Misses $1.28 Estimate, Sales $111.10M Down From $135.70M YoY   Benzinga
04:30PM EDT  China Biologic Reports Financial Results for the Second Quarter of 2020   PR Newswire
04:04AM EDT  Earnings Scheduled For August 17, 2020   Benzinga
Aug 10, 2020
08:01AM EDT  China Biologic Products to Report Second Quarter 2020 Financial Results   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC